Tobramycin pharmacokinetic and pharmacodynamic targets in people with cystic fibrosis. [PDF]
Harwood KH +6 more
europepmc +1 more source
Mechanisms, prevention, and management of aminoglycoside-induced hearing loss in neonates and children: a translational review. [PDF]
Illamola SM +5 more
europepmc +1 more source
Audiologic Assessment and Management of Teprotumumab-Associated Ototoxicity: An Updated Narrative Review. [PDF]
Williams J +4 more
europepmc +1 more source
Cancer therapy-induced ototoxicity: Current challenges and emerging management strategies. [PDF]
Huang Y, Xu B, Chen X, Chen Y, Yu D.
europepmc +1 more source
Ototoxicity Associated with Antineoplastic Agents in the Pediatric Population: An Evidence-Based Review of Auditory Monitoring Strategies and Contemporary Diagnostic Frameworks-Narrative Review. [PDF]
Wojno A +4 more
europepmc +1 more source
Treatment Adaptation to Surgical Timing in Pediatric Hepatoblastoma: A 19-Year Single-Center Experience With Resection and Liver Transplantation. [PDF]
Pellegrinelli C +9 more
europepmc +1 more source
Pharmacogenetic strategies to mitigate cisplatin-induced ototoxicity in head and neck cancer: A cost-minimization analysis with the use of GSTP1 c.313A>G genotyping. [PDF]
Macedo LT +7 more
europepmc +1 more source
Genetic susceptibility to aminoglycoside cochleotoxicity in South African multidrug-resistant and rifampicin-resistant tuberculosis patients. [PDF]
Ghafari N +5 more
europepmc +1 more source
Progressive Sensorineural Hearing Loss Following Cisplatin Chemotherapy: Mechanisms Underlying Cochlear Retention and Long-Term Ototoxicity. [PDF]
Ruggiero A +6 more
europepmc +1 more source
An integration of physiological, morphological and biochemical assessments in studying guinea pig models of ototoxicity and otoprotection-a systematic review. [PDF]
Young YH, Wu PH, Liu SH.
europepmc +1 more source

